Diana O Perkins Selected Research

Prodromal Symptoms

1/2020	Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm.
9/2013	Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.
3/2013	Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
11/2009	The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample.
1/2009	Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.
10/2008	Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study.
8/2003	Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diana O Perkins Research Topics

Disease

45	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2005
36	Schizophrenia (Dementia Praecox) 01/2022 - 12/2002
10	Weight Gain 12/2018 - 12/2002
7	Prodromal Symptoms 01/2020 - 08/2003
3	Mental Disorders (Mental Disorder) 01/2020 - 08/2013
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2009
2	Inflammation (Inflammations) 01/2017 - 03/2015
2	Hypertension (High Blood Pressure) 08/2015 - 08/2014
2	Weight Loss (Weight Reduction) 09/2011 - 09/2005
2	Body Weight (Weight, Body) 06/2009 - 01/2005
1	Neurodevelopmental Disorders 01/2022
1	Cerebral Cortical Thinning 10/2017
1	Atherosclerosis 01/2017
1	Obesity 08/2014
1	Treatment-Resistant Schizophrenia 08/2014
1	Dyslipidemias (Dyslipidemia) 08/2014
1	Type 2 Diabetes Mellitus (MODY) 08/2014
1	Mood Disorders (Mood Disorder) 08/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2009
1	Disease Progression 05/2009
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2007
1	Menstruation Disturbances 07/2007
1	Tardive Dyskinesia 12/2006
1	Eosinophilia 04/2006
1	Agranulocytosis (Granulocytopenia) 04/2006
1	Insulin Resistance 01/2005
1	Psychomotor Agitation (Akathisia) 12/2002

Drug/Important Bio-Agent (IBA)

31	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 12/2002
18	Olanzapine (Zyprexa)FDA Link 09/2011 - 08/2003
10	Risperidone (Risperdal Consta)FDA LinkGeneric 09/2011 - 04/2006
9	Quetiapine Fumarate (Seroquel)FDA Link 09/2011 - 04/2006
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2013
5	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 09/2013
4	Pharmaceutical PreparationsIBA 01/2020 - 05/2003
4	Perphenazine (Trilafon)FDA LinkGeneric 11/2009 - 09/2005
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 05/2010
3	Biological ProductsIBA 01/2021 - 06/2006
3	CytokinesIBA 01/2019 - 10/2017
3	LipidsIBA 08/2015 - 01/2005
3	Glucose (Dextrose)FDA LinkGeneric 06/2009 - 01/2005
3	ziprasidone (Geodon)FDA Link 06/2007 - 04/2006
2	MicroRNAs (MicroRNA)IBA 10/2017 - 01/2007
2	Clozapine (Clozaril)FDA LinkGeneric 08/2014 - 04/2006
2	Triglycerides (Triacylglycerol)IBA 09/2011 - 01/2005
2	Indicators and Reagents (Reagents)IBA 02/2011 - 01/2011
2	Haloperidol (Haldol)FDA LinkGeneric 05/2009 - 12/2005
1	Sp4 Transcription FactorIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	ParvalbuminsIBA 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	SmokeIBA 10/2019
1	antineoplaston A10 (A 10)IBA 04/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2018
1	Lysine (L-Lysine)FDA Link 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017
1	Malondialdehyde (Propanedial)IBA 01/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Hormones (Hormone)IBA 03/2015
1	Prednisolone (Predate)FDA LinkGeneric 03/2013
1	Gonadal HormonesIBA 03/2013
1	RNA (Ribonucleic Acid)IBA 12/2012
1	DNA (Deoxyribonucleic Acid)IBA 12/2012
1	ElementsIBA 10/2012
1	HDL LipoproteinsIBA 09/2011
1	HDL CholesterolIBA 09/2011
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 07/2010
1	Antidepressive Agents (Antidepressants)IBA 11/2009
1	Neuregulin-1 (Neuregulin 1)IBA 10/2008
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2006
1	Amantadine (Aman)FDA LinkGeneric 09/2005
1	Insulin (Novolin)FDA Link 01/2005
1	LeptinIBA 01/2005

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2005
2	Patient Readmission 01/2019 - 12/2002
2	Injections 01/2019 - 11/2017
1	Episode of Care 01/2021
1	Transcutaneous Electric Nerve Stimulation (TENS) 10/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Aftercare (After-Treatment) 03/2008